
The genetic testing company 23andMe has filed for bankruptcy protection in an attempt to sell itself, the American firm has confirmed.
After struggling for years with its business model, 23andMe said it had started voluntary Chapter 11 proceedings in the US Bankruptcy Court for the Eastern District of Missouri.